Bloomberg Originals
@business·5.1M subscribers·49.5K videos
Ebola Is Coming and the U.S. Gov't Screwed Up Treatment
Posted
September 24, 2014
Views
3,371
Likes
26
Comments
12
Engagement
September 24, 2014
3,371
26
12
1.13%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
1:52Now PlayingSept. 24 (Bloomberg) -- ZMapp is a treatment for Ebola that uses human antibodies to create an immunity to the virus. The treatment has been given to some Ebola victims and is credited with saving lives. But there have been no large clinical trials of ZMapp yet. Bloomberg Businessweek's Brendan Greeley explains how government bureaucracy stymied efforts to develop and test ZMapp. Video by: Kelly Buzby, David Yim, Stephanie Davidson.
Subscribe to Bloomberg on YouTube
Bloomberg Television offers extensive coverage and analysis of international business news and stories of global importance. It is available in more than 310 million households worldwide and reaches the most affluent and influential viewers in terms of household income, asset value and education levels. With production hubs in London, New York and Hong Kong, the network provides 24-hour continuous coverage of the people, companies and ideas that move the markets.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
